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1. Introduction 
The four vitamin K-dependent plasma proteins 
participating in blood coagulation (prothrombin, 
factors VII, IX and X) are zymogens of serine endo- 
peptidases [ 1,2] . These proteins bind calcium ions 
and can be adsorbed to barium citrate and similar 
salts of divalent cations. Recently, a new fifth vitamin 
K-dependent protein, arbitrarily referred to as protein 
C, was isolated from bovine plasma [3] . Also, this 
protein binds calcium and can be activated to a serine 
esterase [4]. Its biological function is still unknown. 
The binding of calcium by these proteins is a result 
of vitamin K action, since prothrombin synthesized 
under the influence of vitamin K antagonists does not 
bind calcium [5,6]. 
Prothrombin, factors VII, and IX are single chain 
structures whereas factor X and protein C have two 
polypeptide chains [l-3] . The calcium binding 
vitamin K-dependent structures are in the NHz-termi- 
nal parts of the polypeptide chains and those for 
factor X and protein C, in the NHz-terminal parts of 
the light chains [l] . In these parts of the molecules, 
there is a strong amino acid sequence homology 
between the proteins. Recently a new amino acid, 
y-carboxyglutamic acid, was found in prothrombin 
[7-91. The amino acid is formed by vitamin K-depen- 
dent carboxylation of the first 10 glutamic acid 
residues in prothrombin [ 1 O-l 21. 
Identification of y-carboxyglutamic acid in sequence 
work is complicated by the fact that the amino acid 
decarboxylates when heated in the acid form. We have 
designed a method for mass spectrometric determina- 
tion of y-carboxyglutamic acid as methylesterified 
thiohydantoin derivative [ 111. The method allows 
direct identification of y-carboxyglutamic acid residues 
during automated sequenator degradation of peptides 
and proteins. The complete amino acid sequences of 
prothrombin and factor X were recently published 
[13--l 51. In factor X, however, the exact positions of 
the y-carboxyglutamic acid residues have not yet 
been unambiguously established, although it has been 
shown that a 39-residue peptide from the vitamin 
K-dependent part of prothrombin has approximately 
one extra carboxyl group per glutamic acid residue [ 161 
The light chains of factor X and protein C lend 
themselves well to direct sequenator degradation. We, 
therefore, used the mass spectrometric method to 
locate the y-carboxyglutamic acid residues in these 
proteins. 
2. Materials and methods 
Factors IX, X (pool of factors X1 and X,), and 
protein C were isolated as described earlier, as were 
the light chains of factor X and protein C [3]. 
Automated Edman degradation was performed in a 
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Beckman Sequencer, model 890B, updated with an 
undercut cup and nitrogen flush during high vacuum. 
The vacuum pumps were protected by cool traps in 
dry ice/iso-propanol. The cool traps also minimized 
background in the mass spectra due to contaminants. 
The degradations were performed with a reversed 
delivery sequence of 1 M Quadrol buffer and phenyl 
isothiocyanate, and with double cleavage, as described 
[ 171. Reagents and solvents were purchased from 
Beckman. 50 ~1 of butanedithiol (pract. grade, Fluka) 
was added per 1 of 1 chlorobutane. 3-isothyiocyano- 
1,5 naphthalene disulfonic acid, disodium salt 
(Braunitzer reagent III) was obtained from Pierce. 
The thiazolinone derivatives were converted to 
phenylthiohydantoin derivatives, as described by 
Edman and Begg [ 181, except for the derivatives of 
y-carboxyglutamic acid, which were methylesterified 
by reaction with diazomethane, and converted in 
1 NHClat 50°C [ll]. 
where glutamic acid or y-carboxyglutamic acid were 
suspected. The results are given in fig.1 where they 
are compared with the sequence of prothrombin [ 131. 
The factor X light chain sequence is identical with the 
sequence earlier published by Enfield et al. [ 141, 
except that these authors did not distinguish between 
glutamic acid residues and carboxylated glutamic acid 
residues. In factor X it was possible to identify 37 
residues from the amino terminus. The results show 
that all three proteins sequenced contain y-carboxy- 
glutamic acid residues at positions in homology with 
prothrombin as far as these residues could be identified 
with the exception of position 36 in factor X, which 
does not correspond to a y-carboxyglutamic acid 
residue in prothrombin. 
Phenylthiohydantoin derivatives were identified 
by gas chromatography [ 191, thin-layer chromatography 
[20] or by amino acid analysis after back hydrolysis 
in HI. Methylesterified phenylthiohydantoin derivatives 
of y-carboxyglutamic acid were identified by mass 
spectrometry as described earlier [ 111. Radioactively 
labelled carboxymethyl cysteine derivatives were 
identified by liquid scintillation counting. 
In the light chain of protein C the first nine glutamic 
acid residues were identified as being carboxylated, 
whereas a suspected tenth carboxylated glutamic acid 
corresponding to position 33 in prothrombin could 
not be unambiguously identified despite attemps with 
two different protein preparations. In the position 
corresponding to 24 in prothrombin it could not be 
decided whether the residue was Ser or Cys. 
3. Results 
Factor IX and the light chains of factor X and 
protein C were sequenced in the automatic sequencer 
with mass spectrometric identification at positions 
Factor IX was degraded after modification with 
Braunitzer reagent III [21] in order to avoid contrac- 
tion of the protein film in the spinning cup of the 
sequenator which otherwise occurred during evacua- 
tion with this protein from the first cycle. Despite 
these efforts no more than fourteen residues could be 
identified in factor IX. Carboxylated glutamic acid 
residues were identified in position 7 and 8, otherwise 
the sequence was identical with that published earlier 
P21. 
Gradual decarboxylation of the y-carboxyglutamic 
1 5 1 LI 
Prothrombin Ala Asii Lys Gly Phe Leu Gla Gla - "al Al-g Lys G1y Asrl k" Gla kg G:a cys Ix" GLd Gla Prc. iys Ser hrC G?* 
I'acror x Ala Asn Ser - Pile Leu Gla Gla - "al Lys Cln My Asn Leu Cla Are Gla Cys Leu Gla Gla Ala Cys Ser Leu (:la 
Protein C Ala Asn Ser - Phe Leu Gla Gla - Leu Arg Pro Gly Asn Val Gla Are Gla Lys Ser Gld Gla Va? Cys ? Phe I;ld 
tactor IX Tyr Asr, ser Gly Lys Leu Gla Gla Piie "al Art: - Gly A;n Leu 
30 35 
P~othrombin Gla Ala Phe Gla Aid Leu Gla Ser Leu Ser Ala Thr 
i‘actcx x Gla Ala Arg Gla Val Phe Gla Asp Ala Gla Gin Thr 
Protein C Gla Ala Arg Gla Ile Phe ? Asn Thr ? ? 'Thr 
Fig.1. +Zarboxyglutamic acid residues (Gla) in factor IX, X and protein C. The sequence of prothrombin is shown for comparison. 
The numbering is that of prothrombin. 
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acid residues occurred during the degradation in the 
sequenator. In the mass spectrometrical identification 
the presence of peaks corresponding to y-carboxy- 
glutamic acid were, therefore, regarded as a proof 
of the presence of the amino acid, whereas admixture 
of glutamic acid in the same step was believed to be 
caused by partial decarboxylation of y-carboxy- 
glutamic acid. 
A previous paper showed mass spectra of the 
methylesterified thiohydantoin derivative of glutamic 
acid and of y-carboxyglutamic acid obtained by 
sequenator degradation of prothrombin [l l] . The 
spectra obtained in this investigation were identical 
to the one already published. The intensities of the 
characteristic peaks obtained during degradation of 
factor X are given in table 1. 
4. Discussion 
Owing to slow decarboxylation during the degrada- 
tion in the sequencer, the mass spectrometric method 
used in this investigation gives only qualitative informa- 
tion on the presence of y-carboxyglutamic acid 
residues. However, considering our rather detailed 
knowledge of the y-carboxyglutamic acid residues in 
prothrombin, on which detailed mass spectrometric 
studies have been performed and where y-carboxy- 
glutamic acid residues have been quantitated after 
Table 1 
Relative intensities of molecular ion peaks of PTH-methyl 
glutamic acid (m/e 278), PTH-dimethyl T-carboxyglutamic 
acid (m/e 336), and PTH-trimethyl r-carboxyglutamic acid 
(m/e 350) in the mass spectra from the degradation of 
factor X. Ionizing electron energy 70 eV, probe temperature 
85-90°C. Numbering as in fig.1 
Position no. m/e 278 m/e 336 m/e 350 
7 0.5 1 0.9 
8 0.5 1 0.4 
15 1.0 1 0.3 
17 1.1 1 0.3 
20 1.8 1 0.6 
21 1.2 1 0.4 
26 1.9 1 0.4 
27 1.1 1 0.3 
30 1.6 1 0.2 
33 2.3 1 0.5 
36 2.4 1 0.4 
alkaline hydrolysis and where the number of carboxyl 
groups in the protein has been carefully determined, 
it is likely that there is no microheterogeneity 
due to partially carboxylated glutamic acid residues 
in prothrombin and, by inference, probably not in 
the other vitamin K-dependent proteins either. 
In prothrombin the first ten glutamic acid residues 
are carboxylated to y-carboxygl@_amic acid 
residues, in factor X the eleven first and in protein C 
at least the first nine. The glutamic acid residues are 
carboxylated in a postribosomal vitamin K-dependent 
reaction [lo] . The amino acid sequence gives no 
information about the specificity of the carboxylase 
indicating that an intact tertiary structure is important 
for the carboxylase to recognize the appropriate 
glutamic acid residues. In view of the extensive amino 
acid sequence homology between the vitamin K-depen- 
dent parts of these proteins, they probably have 
similar conformations. This assumption is supported 
by the fact that prothrombin and factor X have similar 
calcium binding properties and that both of them 
bind the first calcium ions with positive cooper- 
ativity [23-251. 
The biological significance of the carboxylated 
glutamic acid residues is illustrated by the fact that 
prothrombin synthetized after administration of 
vitamin K-antagonists is not carboxylated, does not 
bind calcium ions and has no biological activity 
[6,23,26,27]. Likewise, the dicoumarol-induced 
forms of factors IX and X appear not to bind calcium 
ions either and are presumably inactive [3,28]. 
References 
[I] Davie, E. W. and Fujikawa, K. (1975) in Ann. Rev. 
Biochem. 44,799-829. 
[2] Radcliff, R. and Nemersom, Y. (1975) J. Biol. Chem. 250, 
388-395. 
[3] Stenflo, J. (1976) J. Biol. Chem. 251, 355-363. 
[4] Esmon, C. T., Stenflo, J., Suttie, J. W. and Jackson, C. M. 
(1976) J. Biol. Chem. 251, 3052-3056. 
[.5] Stenflo, J. and Ganrot, P. (1972) J. Biol. Chem. 247, 
8160-8166. 
[6] Nelsestuen, G. L. and Suttie, J. W. (1972) Biochemistry 
11,4961-4964. 
[7] Stenflo, J., Fernlund, P., Egan, W. and Roepstorff, P. 
(1974) Proc. Natl. Acad. Sci. USA 71, 2730-2733. 
[S] Magnusson, S., Sottrup-Jensen, L., Petersen, T. F., 
Morris, H. R. and Dell, A. (1974) FEBS Lett. 44, 
189-193. 
295 
Volume 68, number 2 FEBS LETTERS October 1976 
[9] Nelsestuen, G. L., Zytkovicz, T. H. and Howard, J. B. 
(1974) J. Biol. Chem. 249, 6347-6350. 
[lo] Esmon, C. T., Sadowski, J. A. and Suttie, J. W. (1975) 
J. Biol. Chem. 250, 4744-4748. 
[ 1 l] Fernlund, P., Stenflo, J., Roepstorff, P. and Thomsen, J. 
(1975) J. Biol. Chem. 250,6125-6133. 
[12] Morris, H. R., Dell, A., Petersen, T. E., Sottrup-Jensen, L. 
and Magnusson, S. (1976) Biochem. J. 153,663-679. 
[ 131 Magnusson, S., Petersen, T. E., Sottrup-Jensen, L. and 
Claeys, H. (1975) in: Proteases and Biological Control 
(Reich, E., Rifkin, D. B. and Shaw, E. eds.), pp. 123-149, 
Cold Spring Harbor Laboratory. 
[ 141 Enfield, D. L., Ericsson, L. H., Walsh, K. A., Neurath, H. 
and Titani, K. (1975) Proc. Natl. Acad. Sci. USA 72, 
16-19. 
[18] Edman, P. and Begg, G. (1967) Eur. J. Biochem. 1,80-91 
[19] Pisano, J. J., Bronzert, T. J. and Brewer, H. B. (1972) 
Anal. Biochem. 45,43-59. 
[20] Kulbe, K. D. (1974) Anal. Biochem. 59,564-575. 
[21] Braunitzer, G., Schrank, B., Ruhfus, A., Petersen, S. and 
Petersen, U. (1971) Hoppe-Seyler’s Z. Physiol. Chem. 
352,1730-1732. 
[ 151 Titani, K., Enfield, D. L., Ericsson, L. H., Walsh, K. A. 
and Neurath, H. (1975) Proc. Natl. Acad. Sci. USA 72, 
3082-3086. 
[22] Fujikawa, K., Coan, M. H., Enfield, D. L., Titani, K., 
Ericsson, L. H. and Davie, E. W. (1974) Proc. Natl. 
Acad. Sci. USA 71,427-430. 
[23] Stenflo, J. and Ganrot, P. 0. (1973) Biochim. Biophys. 
Res. Commun. 50,98-104. 
[24] Bajaj, S. P., Butkowski, R. J. and Mann, K. (1975) 
J. Biol. Chem. 250, 2150-2156. 
[25] Henriksen, R. A. and Jackson, C. M. (1975) Arch. 
Biochem. Biophys. 170, 149-159. 
[26] Nelsestuen, G. L. and Suttie, J. W. (1972) J. Biol. 
Chem. 247,8176-8182. 
[16] Howard, J. B. and Nelsestuen, G. L. (1975) Proc. Natl. [27] Stenflo, J. (1974) J. Biol. Chem. 249,5527-5535. 
Acad. Sci. USA 72,1281-1285. [28] Reekers, P. P. M., Lindhout, M. J., Kop-Klassen, 
[ 171 Thomsen, J., Bucher, D., Brunfeldt, K., Nexa, E. and B. H. M. and Hemker, H. C. (1973) Biochim. Biophys. 
Olesen, H. (1976) Eur. J. Biochem. in press. Acta 317, 559-562. 
296 
